However, researchers are exploring new treatments that involve drugs that prevent angiogenesis (the process by which new blood vessels are formed) and can slow or prevent tumor growth.TRC105 is an experimental drug that blocks angiogenesis, and has been studied for possible use in treating different kinds of cancer.